FDA Panel Calls for Restrictions on Johnson & Johnson (Jobs) and Amgen (Jobs) Anemia Drugs

SILVER SPRING, Md., May 10 (Reuters) - A U.S. advisory panel on Thursday called for marketing restrictions on popular anemia drugs sold by Amgen Inc. (AMGN.O: Quote, Profile , Research) and Johnson & Johnson(JNJ.N: Quote, Profile , Research).

>>> Discuss This Story